<p>Chris Sweeney discusses this ANZUP trial which adds more phase 3 data to the high risk prostate cancer space.</p>

Episode 528: ESMO 2026 - LITESPARK 012

Broadcasting the latest developments in GU cancer

Hosted by Brian Rini and Tom Powles 

Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center
Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London